文献速递衰弱、肌少症与跌倒老年慢病共病管理老年综合评估

衰弱合并晚期慢性肾脏病老年人的结局与照护优先事项:多专业范围综述

Outcomes and care priorities for older people living with frailty and advanced chronic kidney disease: a multi-professional scoping review.
PubMed 文献 · Age Ageing · 2022-01-01

该范围综述纳入90项研究,系统梳理≥65岁衰弱合并晚期慢性肾脏病(ACKD 4-5期)老年人的衰弱识别工具、干预研究及报告结局。最常报告的衰弱测量为衰弱表型,最常报告的结局为死亡、住院和医疗利用,患者报告结局以健康相关生活质量最常见;干预研究少,患者和照护者视角证据有限。

要点

  • 衰弱表型是该类人群最常报告的衰弱测量工具。
  • 死亡、住院和医疗利用是最常报告的结局指标。
  • 干预研究及患者、照护者视角证据明显不足。

核心结论

  • 该范围综述明确了≥65岁衰弱合并ACKD 4-5期老年人研究中亟需进一步探索的重要领域。
  • 需进一步研究包括识别衰弱的「金标准」测量、干预措施及对患者重要结局指标的改进。
  • 未来研究应关注照护者及照护者负担,并优先设定研究方向。

研究设计与样本

  • 遵循PRISMA-Scr指南开展的范围综述,检索9个数据库,由5人评审团队按既定纳入和排除标准筛选文献。
  • 共纳入90项研究,采用世界卫生组织《国际功能、残疾和健康分类》对结局进行跨域映射。

主要发现

  • 最常报告的衰弱测量工具为衰弱表型。
  • 最常报告的结局为死亡、住院和医疗利用。
  • 健康相关生活质量是最常见的患者报告结局测量。
  • 干预研究较少,患者和照护者视角的证据有限。

关键数值与推荐

  • 研究对象为≥65岁衰弱合并晚期慢性肾脏病(ACKD 4-5期)的老年人。

临床怎么用

  • 临床评估衰弱时可参考最常使用的衰弱表型,但需认识到识别衰弱的「金标准」尚未确立。
  • 照护决策应关注死亡、住院和医疗利用等高频报告结局,同时重视患者报告的健康相关生活质量。
  • 应关注患者和照护者视角,评估照护者负担并纳入照护计划。

局限性

  • 干预研究较少,患者和照护者视角的证据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The growing older population with advanced chronic kidney disease (ACKD stages 4-5) poses a challenge for healthcare worldwide. The high prevalence of frailty and associated adverse health outcomes highlights concerns for management and interventions specific to this population. The aim was to objectively review the evidence relating to older people (≥65 years) living with frailty and ACKD. More specifically how frailty is identified, what interventions have been studied and what outcomes have been reported including outcomes important to patients, families and carers. A scoping review was undertaken following the PRISMA-Scr guidelines. Nine databases were searched and a review team of five people followed a process using defined inclusion and exclusion criteria. Data were then analysed to answer the specific questions of the review. The World Health Organization's International Classification of Functioning Disability and Health was used to map outcomes across the domains. A total of 90 studies were included. The most reported frailty measure was the frailty phenotype. The most reported outcomes were mortality, hospitalisation and healthcare utilisation. Health-related quality of life was the most common patient-reported outcome measure. There were few intervention studies and limited evidence of patient and carer perspectives. This scoping review highlights important areas for further research in older people living with frailty and ACKD. This includes a 'gold standard' measure for identifying frailty, interventions and improvements in outcome measures that matter to patients (including studies that focus on carers and carer burden) and priority setting for future research.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Hurst H, Young HML, Nixon AC, et al. Outcomes and care priorities for older people living with frailty and advanced chronic kidney disease: a multi-professional scoping review. Age Ageing. 2022. PMID: 36580559. doi:10.1093/ageing/afac296

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。